by jlohrconsulting | Sep 3, 2025 | Uncategorized
Am J Ther. 2025 Sep 4. doi: 10.1097/MJT.0000000000002035. Online ahead of print. NO ABSTRACT PMID:40899867 | DOI:10.1097/MJT.0000000000002035
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Hand (N Y). 2025 Sep 3:15589447251366676. doi: 10.1177/15589447251366676. Online ahead of print. ABSTRACT BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1) are approved for type 2 diabetes treatment. Given the link between diabetes-associated metabolic...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Behav Sleep Med. 2025 Sep 3:1-13. doi: 10.1080/15402002.2025.2555864. Online ahead of print. ABSTRACT OBJECTIVES: We developed and evaluated the psychometric properties of the Sleep Acceptance Scale (SAS), a tool designed to measure sleep acceptance via cognitive and...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
J Cardiovasc Nurs. 2025 Sep 3. doi: 10.1097/JCN.0000000000001255. Online ahead of print. ABSTRACT BACKGROUND: Older adults with heart disease experience higher rates of depression and insomnia compared with heart disease-free peers. Aside from these psychological...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Invest Ophthalmol Vis Sci. 2025 Sep 2;66(12):8. doi: 10.1167/iovs.66.12.8. ABSTRACT PURPOSE: The significant lens chaperone protein α-crystallin (αABc), comprised of αA-crystallin (αAc) and αB-crystallin (αBc) subunits, is found to form membrane-bound aggregates with...
by jlohrconsulting | Sep 3, 2025 | Uncategorized
Can J Psychiatry. 2025 Sep 3:7067437251374600. doi: 10.1177/07067437251374600. Online ahead of print. NO ABSTRACT PMID:40900098 | DOI:10.1177/07067437251374600
Recent Comments